Czech National Bank Increases Holdings in McKesson Corporation $MCK

Czech National Bank lifted its holdings in McKesson Corporation (NYSE:MCK) by 3.0% in the fourth quarter, Holdings Channel reports. The fund owned 32,546 shares of the company’s stock after purchasing an additional 955 shares during the quarter. Czech National Bank’s holdings in McKesson were worth $26,697,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MCK. GGM Financials LLC purchased a new stake in McKesson during the third quarter valued at approximately $25,000. State of Wyoming bought a new stake in shares of McKesson in the 2nd quarter valued at approximately $29,000. Hopwood Financial Services Inc. purchased a new position in shares of McKesson in the 3rd quarter worth approximately $31,000. Board of the Pension Protection Fund bought a new position in shares of McKesson during the 4th quarter valued at approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC bought a new position in shares of McKesson during the 3rd quarter valued at approximately $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on MCK shares. Wells Fargo & Company raised their price target on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. JPMorgan Chase & Co. boosted their price objective on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. TD Cowen increased their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research note on Thursday, February 5th. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $966.00 price target on shares of McKesson in a report on Thursday, January 29th. Thirteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

Insider Activity at McKesson

In related news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. This trade represents a 45.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 over the last ninety days. 0.08% of the stock is currently owned by company insiders.

McKesson Stock Down 0.3%

MCK opened at $879.57 on Thursday. The business has a fifty day moving average of $906.79 and a 200 day moving average of $837.49. The stock has a market cap of $107.74 billion, a P/E ratio of 25.30, a PEG ratio of 1.42 and a beta of 0.38. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same quarter last year, the firm posted $8.03 earnings per share. The business’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts anticipate that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.